Influenza Virus Vaccine, Monovalent A/H1N1 A/California/7/2009 NYMC X-179A

BIOLOGICAL2 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID)

Conditions

Influenza

Phase 2

Peds Sanofi H1N1 Influenza Vaccine Administered at Two Dose Levels

CompletedNCT00944073

National Institute of Allergy and Infectious Diseases (NIAID)Influenza

Start: 2009-08-31End: 2010-04-30Updated: 2015-02-18

Sanofi H1N1 Influenza Vaccine Administered at Different Dose Levels With and Without AS03 Adjuvant in Healthy Adult and Elderly Populations

CompletedNCT00963157

National Institute of Allergy and Infectious Diseases (NIAID)Influenza

Start: 2009-09-30End: 2010-12-31Updated: 2014-12-24

Related Papers

Immunogenicity and safety of varying dosages of a monovalent 2009 H1N1 influenza vaccine given with and without AS03 adjuvant system in healthy adults and older persons.

2012-07-1036 citations